Strategic Approach for Diabetes Mellitus Type 2 Patients with Acute Limb Ischemia and COVID-19: Is Amputation Mandatory? Case Series

Bagus Aulia Mahdi, Satyawardhana, Hermina Novida, Agil Al Jufri, Muhammad Zulfadly Nuralim, Dhihinitia Jiwangga, Arif Rachman

Abstract

Diabetes Mellitus Type 2 in COVID-19 patients accompanied by acute limb injury makes the treatment more complex. The aim of this case report is to describe the best treatment strategy for patients with diabetes mellitus type 2 with acute limb ischemia. We present two cases of patients who tested positive for COVID-19 by nasopharyngeal swab with a history of diabetes mellitus type 2, with clinical signs of acute limb ischemia. Occlusion sites of the arteries were confirmed by CT angiography in the first case, and by Doppler vascular ultrasound in the second case. Nonetheless, despite the revascularization, fine blood sugar control, and controlled COVID-19 management, amputation had to be performed since the previous attempts at treatment produced unsatisfactory results. An improvement of clinical condition after amputation was reported. Diabetes mellitus type 2 accompanied with acute limb ischemia and COVID-19 is a complex case that needs good hyperglycemic control management, comprehensive COVID-19 treatment, and immediate treatment for acute limb ischemia. Revascularization strategy appears to be insufficient, and all clinical and laboratory aspects showed promising improvement following the amputation.

 

Keywords: diabetes mellitus, acute limb ischemia, COVID-19, revascularization, amputation.


Full Text:

PDF


References


AGGARWAL G., LIPPI G., LAVIE C. J., HENRY B. M., and SANCHIS-GOMAR F. Diabetes Mellitus Association with Coronavirus Disease 2019 (COVID-19) Severity and Mortality: A Pooled Analysis. Journal of Diabetes, 2020, 12(11): 851-855. https://doi.org/10.1111/1753-0407.13091

PARVEEN R., SEHAR N., BAJPAI R., and AGARWAL N. B. Association of diabetes and hypertension with disease severity in COVID-19 patients: A systematic literature review and exploratory meta-analysis. Diabetes Research and Clinical Practice, 2020, 166: 108295. https://doi.org/10.1016/j.diabres.2020.108295

KAUR P., QAQA F., RAMAHI A., SHAMOON Y., SINGHAL M., SHAMOON F., MAROULES M., and SINGH B. Acute upper limb ischemia in a patient with COVID-19. Hematology/Oncology and Stem Cell Therapy, 2020. https://doi.org/10.1016/j.hemonc.2020.05.001

GALANIS N., STAVRAKA C., AGATHANGELIDIS F., PETSATODIS E., GIANKOULOF C., and GIVISSIS P. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. Journal of Surgical Case Reports, 2020, 2020(6): rjaa204. https://doi.org/10.1093/jscr/rjaa204

BELLIDO V., & PÉREZ A. Inpatient Hyperglycemia Management and COVID-19. Diabetes Therapy, 2021, 12: 121–132. https://doi.org/10.1007/s13300-020-00966-z

KICHLOO A., DETTLOFF K., ALJADAH M., ALBOSTA M., JAMAL S., SINGH J., WANI F., KUMAR A., VALLABHANENI S., and KHAN M. Z. COVID-19 and Hypercoagulability: A Review. Clinical and Applied Thrombosis/Hemostasis, 2020, 26: 1-9. https://doi.org/10.1177/1076029620962853

ABOU-ISMAIL M. Y., DIAMOND A., KAPOOR S., ARAFAH Y., and NAYAK L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thrombosis Research, 2020, 194: 101-115. https://doi.org/10.1016/j.thromres.2020.06.029

RAJPAL A., RAHIMI L., and ISMAIL-BEIGI F. Factors Leading to High Morbidity and Mortality of COVID-19 in Patients with Type 2 Diabetes. Journal of Diabetes, 2020, 12(12): 895-908. https://doi.org/10.1111/1753-0407.13085

SINGHANIA N., BANSAL S., NIMMATOORI D. P., EJAZ A. A., MCCULLOUGH P. A., and SINGHANIA G. Current Overview on Hypercoagulability in COVID-19. American Journal of Cardiovascular Drugs, 2020, 20(5): 393-403. https://doi.org/10.1007/s40256-020-00431-z

GERHARD-HERMAN M. D., GORNIK H. L., BARRETT C., BARSHES N. R., CORRIERE M. A., DRACHMAN D. E., FLEISHER L. A., FOWKES F. G., HAMBURG N. M., KINLAY S., LOOKSTEIN R., MISRA S., MUREEBE L., OLIN J. W., PATEL R. A., REGENSTEINER J. G., SCHANZER A., SHISHEHBOR M. H., STEWART K. J., TREAT-JACOBSON D., and WALSH M. E. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2017, 135(12): e686–e725. https://doi.org/10.1161/CIR.0000000000000470

OLINIC D.-M., STANEK A., TĂTARU D.-A., HOMORODEAN C., and OLINIC M. Acute Limb Ischemia: An Update on Diagnosis and Management. Journal of Clinical Medicine, 2019, 8(8): 1215. https://doi.org/10.3390/jcm8081215

FUKUDA I., CHIYOYA M., TANIGUCHI S., and FUKUDA W. Acute limb ischemia: contemporary approach. General Thoracic and Cardiovascular Surgery, 2015, 63(10): 540-548. https://doi.org/10.1007/s11748-015-0574-3

GILL P., SILVERMAN S., BENNETT P., and LIP G. Peripheral arterial disease and Virchow’s triad. Thrombosis and Haemostasis, 2017, 101(6): 1032-1040. https://doi.org/10.1160/TH08-08-0518

BACCELLIERI D., BILMAN V., APRUZZI L., MONACO F., D'ANGELO A., LOSCHI D., MELISSANO G., and CHIESA R. A Case of Covid-19 Patient with Acute Limb Ischemia and Heparin Resistance. Annals of Vascular Surgery, 2020, 68: 88-92. https://doi.org/10.1016/j.avsg.2020.06.046

KAUR P., POSIMREDDY S., SINGH B., QAQA F., HABIB H. A., MAROULES M., and SHAMOON F. COVID-19 Presenting as Acute Limb Ischaemia. European Journal of Case Reports in Internal Medicine, 2020, 7(6). https://doi.org/10.12890/2020_001724


Refbacks

  • There are currently no refbacks.